8th LAFM Summit 2025

Biopharma R AND D currently faces a weaker funding period and fluctuating headcounts all while scientific operations and investments continue - seen as Wuxi and Johnson and Johnson expand their R AND D collaboration and Roche expands its research capabilities. As the backbone of scientific support, asset managers, facilities, and procurement professionals must embrace more intelligent utilization of lab operations systems and promote their vital shift towards complete digitization.
 
The 8th Lab Asset and Facility Management Summit (LAFM) is returning to unite 200+ senior lab operations, facilities, asset and procurement professionals across biopharma, CDMOs, CROs, and diagnostics, to live and breathe lean operations as a non-negotiable in the lab environment and supporting complete integration of all facets of operations within budget.